Nutritional and surgical aspects in prostate disorders

References

• Adorini, L., G. Penna, B. Fibbi, and M. Maggi. 2010. Vitamin D receptor agonists target static, dynamic, and inflammatory components of benign prostatic hyperplasia. Annals of the New York Academy of Sciences 1193 (1):146–52. doi: 10.1111/j.1749-6632.2009.05299.x.
   PubMedGoogle Scholar
• Antwi, S. O., S. E. Steck, H. Zhang, L. Stumm, J. Zhang, T. G. Hurley, and J. R. Hebert. 2015a. Plasma carotenoids and tocopherols in relation to prostate-specific antigen (PSA) levels among men with biochemical recurrence of prostate cancer. Cancer Epidemiology 39 (5):752–762. doi: 10.1016/j.canep.2015.06.008.
   PubMed Web of Science ®Google Scholar
• Antwi, S. O., S. E. Steck, L. J. Su, J. R. Hebert, H. Zhang, E. T. Fontham, G. J. Smith, J. T. Bensen, J. L. Mohler, and L. Arab. 2015b. Dietary, supplement, and adipose tissue tocopherol levels in relation to prostate cancer aggressiveness among African and European Americans: The North Carolina-Louisiana Prostate Cancer Project (PCaP). The Prostate 75 (13):1419–1435. doi: 10.1002/pros.23025.
   PubMed Web of Science ®Google Scholar
• AUA Practice Guidelines Committee. 2003. AUA guideline on management of benign prostatic hyperplasia 2003. Chapter 1: Diagnosis and treatment recommendations. The Journal of Urology 170 (2):530–47.
   PubMed Web of Science ®Google Scholar
• Aune, D., D. A. Navarro Rosenblatt, D. S. Chan, A. R. Vieira, R. Vieira, D. C. Greenwood, L. J. Vatten, and T. Norat. 2015. Dairy products, calcium, and prostate cancer risk: A systematic review and meta-analysis of cohort studies. The American Journal of Clinical Nutrition 101 (1):87–117. doi: 10.3945/ajcn.113.067157.
   PubMed Web of Science ®Google Scholar
• Barnard, R., W. Aronson, C. Tymchuk, and T. Ngo. 2002. Prostate cancer: Another aspect of the insulin-resistance syndrome? Obesity Reviews: An Official Journal of the International Association for the Study of Obesity 3 (4):303–8. doi: 10.1046/j.1467-789x.2002.00081.x.
   PubMedGoogle Scholar
• Bemis, D. L., J. L. Capodice, A. G. Anastasiadis, A. E. Katz, and R. Buttyan. 2005. Zyflamend, a unique herbal preparation with nonselective COX inhibitory activity, induces apoptosis of prostate cancer cells that lack COX-2 expression. Nutrition and Cancer 52 (2):202–212. doi: 10.1207/s15327914nc5202_10.
   PubMed Web of Science ®Google Scholar
• Bilen, M. A., S.-H. Lin, D. G. Tang, K. Parikh, M.-H. Lee, S.-C J. Yeung, and S.-M. Tu. 2015. Maintenance therapy containing metformin and/or Zyflamend for advanced prostate Cancer: A case series. Case Reports in Oncological Medicine 2015:1–5. doi: 10.1155/2015/471861.
   Google Scholar
• Bistulfi, G., B. A. Foster, E. Karasik, B. Gillard, J. Miecznikowski, V. K. Dhiman, and D. J. Smiraglia. 2011. Dietary folate deficiency blocks prostate cancer progression in the TRAMP model. Cancer Prevention Research (Philadelphia, PA) 4 (11):1825–1834. doi: 10.1158/1940-6207.CAPR-11-0140.
   PubMed Web of Science ®Google Scholar
• Black, L., M. J. Naslund, T. D. Gilbert, E. A. Davis, and D. A. Ollendorf. 2006. An examination of treatment patterns and costs of care among patients with benign prostatic hyperplasia. The American Journal of Managed Care 12 (4 Suppl):S99–S110.
   PubMed Web of Science ®Google Scholar
• Bosland, M. C., I. Kato, A. Zeleniuch-Jacquotte, J. Schmoll, E. Enk Rueter, J. Melamed, M. X. Kong, V. Macias, A. Kajdacsy-Balla, L. H. Lumey, et al. 2013. Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: A randomized trial. JAMA 310 (2):170–8. doi: 10.1001/jama.2013.7842.
   PubMed Web of Science ®Google Scholar
• Bourke, L., H. Doll, H. Crank, A. Daley, D. Rosario, and J. M. Saxton. 2011. Lifestyle intervention in men with advanced prostate cancer receiving androgen suppression therapy: A feasibility study. Cancer Epidemiology Biomarkers & Prevention 20 (4):647–657. doi: 10.1158/1055-9965.EPI-10-1143.
   PubMed Web of Science ®Google Scholar
• Bravi, F., C. Bosetti, L. Dal Maso, R. Talamini, M. Montella, E. Negri, V. Ramazzotti, S. Franceschi, and C. La Vecchia. 2006. Food groups and risk of benign prostatic hyperplasia. Urology 67 (1):73–79. doi: 10.1016/j.urology.2005.07.030.
   PubMed Web of Science ®Google Scholar
• Bristow, S. M., M. J. Bolland, G. S. MacLennan, A. Avenell, A. Grey, G. D. Gamble, and I. R. Reid. 2013. Calcium supplements and cancer risk: A meta-analysis of randomised controlled trials. The British Journal of Nutrition 110 (8):1384–1393. doi: 10.1017/S0007114513001050.
   PubMed Web of Science ®Google Scholar
• Brooks, J. D., V. G. Paton, and G. Vidanes. 2001. Potent induction of phase 2 enzymes in human prostate cells by sulforaphane. Cancer Epidemiology and Prevention Biomarkers 10 (9):949–954.
   PubMed Web of Science ®Google Scholar
• Calle, E. E., C. Rodriguez, E. J. Jacobs, M. L. Almon, A. Chao, M. L. McCullough, H. S. Feigelson, and M. J. Thun. 2002. The American cancer society cancer prevention study II nutrition cohort: Rationale, study design, and baseline characteristics. Cancer 94 (9):2490–2501. doi: 10.1002/cncr.101970.
   PubMed Web of Science ®Google Scholar
• Chan, J. M., M. J. Stampfer, E. Giovannucci, P. H. Gann, J. Ma, P. Wilkinson, C. H. Hennekens, and M. Pollak. 1998. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study. Science (New York, NY) 279 (5350):563–6. doi: 10.1126/science.279.5350.563.
   Google Scholar
• Chen, J. X., G. Li, H. Wang, A. Liu, M.-J. Lee, K. Reuhl, N. Suh, M. C. Bosland, and C. S. Yang. 2016. Dietary tocopherols inhibit PhIP-induced prostate carcinogenesis in CYP1A-humanized mice. Cancer Letters 371 (1):71–78. doi: 10.1016/j.canlet.2015.11.010.
   PubMed Web of Science ®Google Scholar
• Cheung, E., J. Pinski, T. Dorff, S. Groshen, D. I. Quinn, C. P. Reynolds, B. J. Maurer, P. N. Lara, D. D. Tsao-Wei, P. Twardowski, et al. 2009. Oral fenretinide in biochemically recurrent prostate cancer: A California cancer consortium phase II trial. Clinical Genitourinary Cancer 7 (1):43–50. doi: 10.3816/CGC.2009.n.008.
   PubMed Web of Science ®Google Scholar
• Christensen, M. J., T. E. Quiner, H. L. Nakken, E. D. Lephart, D. L. Eggett, and P. M. Urie. 2013. Combination effects of dietary soy and methylselenocysteine in a mouse model of prostate cancer. The Prostate 73 (9):986–95. doi: 10.1002/pros.22646.
   PubMed Web of Science ®Google Scholar
• Chyou, P. H., A. M. Nomura, G. N. Stemmermann, and J. H. Hankin. 1993. A prospective study of alcohol, diet, and other lifestyle factors in relation to obstructive uropathy. The Prostate 22 (3):253–64. doi: 10.1002/pros.2990220308.
   PubMed Web of Science ®Google Scholar
• Coker, T. J., and D. M. Dierfeldt. 2016. Acute bacterial prostatitis: Diagnosis and management. American Family Physician 93 (2):114–20.
   PubMed Web of Science ®Google Scholar
• Collin, S. M., 2013. Folate and B12 in prostate cancer. BMC Public Health 14 (1):1326–63.
   Google Scholar
• Collins, M. M., J. B. Meigs, M. J. Barry, E. W. Corkery, E. Giovannucci, and I. Kawachi. 2002. Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. The Journal of Urology 167 (3):1363–1366. doi: 10.1016/S0022-5347(05)65301-3.
   PubMed Web of Science ®Google Scholar
• Costello, L., and, R. Franklin. 2000. The intermediary metabolism of the prostate: A key to understanding the pathogenesis and progression of prostate malignancy. Oncology 59 (4):269–82. doi: 10.1159/000012183.
   PubMed Web of Science ®Google Scholar
• Cui, R., Z.-Q. Liu, and Q. Xu. 2014. Blood α-tocopherol, γ-tocopherol levels and risk of prostate cancer: A meta-analysis of prospective studies. PloS One 9 (3):e93044. doi: 10.1371/journal.pone.0093044.
   PubMed Web of Science ®Google Scholar
• Das, K., and N. Buchholz. 2019. Benign prostate hyperplasia and nutrition. Clinical Nutrition ESPEN 33:5–11. doi: 10.1016/j.clnesp.2019.07.015.
   PubMed Web of Science ®Google Scholar
• Davis, N. G., and M. Silberman. 2019. Bacterial acute prostatitis. In StatPearls. Treasure Island, FL: StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK459257/. Last update: October 7, 2021.
   Google Scholar
• Dorff, T. B., S. Groshen, D. D. Tsao-Wei, S. Xiong, M. E. Gross, N. Vogelzang, D. I. Quinn, and J. K. Pinski. 2014. A Phase II trial of a combination herbal supplement for men with biochemically recurrent prostate cancer. Prostate Cancer and Prostatic Diseases 17 (4):359–365. doi: 10.1038/pcan.2014.37.
   PubMed Web of Science ®Google Scholar
• Drake, I., E. Sonestedt, B. Gullberg, G. Ahlgren, A. Bjartell, P. Wallström, and E. Wirfält. 2012. Dietary intakes of carbohydrates in relation to prostate cancer risk: A prospective study in the Malmö Diet and Cancer cohort. The American Journal of Clinical Nutrition 96 (6):1409–18. doi: 10.3945/ajcn.112.039438.
   PubMed Web of Science ®Google Scholar
• Dunn, M. W., and M. W. Kazer. 2011. Prostate cancer overview. Seminars in Oncology Nursing 27 (4):241–50. doi: 10.1016/j.soncn.2011.07.002.
   Google Scholar
• Espinosa, G. 2013. Nutrition and benign prostatic hyperplasia. Current Opinion in Urology 23 (1):38–41. doi: 10.1097/MOU.0b013e32835abd05.
   PubMed Web of Science ®Google Scholar
• Espinosa, G., R. Esposito, A. Kazzazi, and B. Djavan. 2013. Vitamin D and benign prostatic hyperplasia–a review. The Canadian Journal of Urology 20 (4):6820–5.
   PubMed Web of Science ®Google Scholar
• Farnsworth, W. E., and J. R. Brown. 1963. Testosterone metabolism in the prostate. National Cancer Institute Monograph 12:323–9.
   PubMedGoogle Scholar
• Fokidis, H. B., M. Yieng Chin, V. W. Ho, H. H. Adomat, K. K. Soma, L. Fazli, K. M. Nip, M. Cox, G. Krystal, A. Zoubeidi, et al. 2015. A low carbohydrate, high protein diet suppresses intratumoral androgen synthesis and slows castration-resistant prostate tumor growth in mice. The Journal of Steroid Biochemistry and Molecular Biology 150:35–45., doi: 10.1016/j.jsbmb.2015.03.006.
   PubMed Web of Science ®Google Scholar
• Fontana, L., R. M. Adelaiye, A. L. Rastelli, K. M. Miles, E. Ciamporcero, V. D. Longo, H. Nguyen, R. Vessella, and R. Pili. 2013. Dietary protein restriction inhibits tumor growth in human xenograft models of prostate and breast cancer. Oncotarget 4 (12):2451–61. doi: 10.18632/oncotarget.1586.
   PubMedGoogle Scholar
• Foo, K. T. 2017. Pathophysiology of clinical benign prostatic hyperplasia. Asian Journal of Urology 4 (3):152–7. doi: 10.1016/j.ajur.2017.06.003.
   PubMed Web of Science ®Google Scholar
• Freedland, S. J., J. Mavropoulos, A. Wang, M. Darshan, W. Demark-Wahnefried, W. J. Aronson, P. Cohen, D. Hwang, B. Peterson, T. Fields, et al. 2008. Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis. The Prostate 68 (1):11–9. doi: 10.1002/pros.20683.
   PubMed Web of Science ®Google Scholar
• Fried, M. 2018. Prostate problems. In Handbook of outpatient medicine, ed. E. Sydney, E. Weinstein, and L. M. Rucker, pp. 477–90, Cham, Switzerland: Springer.
   Google Scholar
• Friederich, M., C. Theurer, and G. Schiebel-Schlosser. 2000. [Prosta Fink Forte capsules in the treatment of benign prostatic hyperplasia. Multicentric surveillance study in 2245 patients]. Forschende Komplementarmedizin Und Klassische Naturheilkunde = Research in Complementary and Natural Classical Medicine 7 (4):200–204. doi: 10.1159/000021344.
   PubMedGoogle Scholar
• Galeone, C., C. Pelucchi, R. Talamini, E. Negri, L. Dal Maso, M. Montella, V. Ramazzotti, S. Franceschi, and C. La Vecchia. 2007. Onion and garlic intake and the odds of benign prostatic hyperplasia. Urology 70 (4):672–676. doi: 10.1016/j.urology.2007.06.1099.
   PubMed Web of Science ®Google Scholar
• Gautam, N., A. K. Mantha, and S. Mittal. 2014. Essential oils and their constituents as anticancer agents: A mechanistic view. BioMed Research International 2014:154106. doi: 10.1155/2014/154106.
   PubMed Web of Science ®Google Scholar
• Giubilei, G., N. Mondaini, A. Minervini, C. Saieva, A. Lapini, S. Serni, R. Bartoletti, and M. Carini. 2007. Physical activity of men with chronic prostatitis/chronic pelvic pain syndrome not satisfied with conventional treatments-could it represent a valid option? The physical activity and male pelvic pain trial: a double-blind, randomized study. The Journal of Urology 177 (1):159–165. doi: 10.1016/j.juro.2006.08.107.
   PubMed Web of Science ®Google Scholar
• Gómez, Y., F. Arocha, F. Espinoza, D. Fernández, A. Vásquez, and V. Granadillo. 2007. Zinc levels in prostatic fluid of patients with prostate pathologies. Investigacion Clinica 48 (3):287–94.
   PubMedGoogle Scholar
• Gat, Y., and M. Goren. 2010. Diagnosis and treatment of vericocele and prostate disorders. U.S. Patent Application No. 20100204639(A1). Washington, DC: U.S. Patent and Trademark Office.
   Google Scholar
• Gu, F. 1997. Changes in the prevalence of benign prostatic hyperplasia in China. Chinese Medical Journal 110(3):163–6.
   PubMed Web of Science ®Google Scholar
• Hamilton-Reeves, J. M., S. Banerjee, S. K. Banerjee, J. M. Holzbeierlein, J. B. Thrasher, S. Kambhampati, J. Keighley, and P. Van Veldhuizen. 2013. Short-term soy isoflavone intervention in patients with localized prostate cancer: A randomized, double-blind, placebo-controlled trial. PLoS One 8 (7):e68331. doi: 10.1371/journal.pone.0068331.
   PubMed Web of Science ®Google Scholar
• Hartman, R., M. Mark, and F. Soldati. 1996. Inhibition of 5a-reductase and aromatase by PHL-00801 (Prostatonin), a combination of PY 102 (Pygeum africanum) and UR 102 (Urtica dioica) extracts. Phytomedicine 3 (2):121–128. doi: 10.1016/S0944-7113(96)80025-0.
   PubMed Web of Science ®Google Scholar
• Hayward, S. W., and G. R. Cunha. 2000. The prostate: Development and physiology. Radiologic Clinics of North America 38 (1):1–14. doi: 10.1016/S0033-8389(05)70146-9.
   PubMed Web of Science ®Google Scholar
• Heber, D., 2002. Prostate enlargement: the canary in the coal mine? Oxford University Press.
   Google Scholar
• Huang, M., A. Koizumi, S. Narita, T. Inoue, N. Tsuchiya, H. Nakanishi, K. Numakura, H. Tsuruta, M. Saito, S. Satoh, et al. 2016. Diet-induced alteration of fatty acid synthase in prostate cancer progression. Oncogenesis 5 (2):e195–e195. doi: 10.1038/oncsis.2015.42.
   PubMedGoogle Scholar
• Huang, M., S. Narita, K. Numakura, H. Tsuruta, M. Saito, T. Inoue, Y. Horikawa, N. Tsuchiya, and T. Habuchi. 2012. A high-fat diet enhances proliferation of prostate cancer cells and activates MCP-1/CCR2 signaling. The Prostate 72 (16):1779–88. doi: 10.1002/pros.22531.
   PubMed Web of Science ®Google Scholar
• Huang, Y., R. Wu, Z.-Y. Su, Y. Guo, X. Zheng, C. S. Yang, and A.-N. Kong. 2017. A naturally occurring mixture of tocotrienols inhibits the growth of human prostate tumor, associated with epigenetic modifications of cyclin-dependent kinase inhibitors p21 and p27. The Journal of Nutritional Biochemistry 40:155–163. doi: 10.1016/j.jnutbio.2016.10.019.
   PubMed Web of Science ®Google Scholar
• Jackson, M. D., N. D. McFarlane-Anderson, G. A. Simon, F. I. Bennett, and S. P. Walker. 2010. Urinary phytoestrogens and risk of prostate cancer in Jamaican men. Cancer Causes & Control: CCC 21 (12):2249–57. doi: 10.1007/s10552-010-9648-9.
   PubMed Web of Science ®Google Scholar
• Jones, S., N. V. Fernandes, H. Yeganehjoo, R. Katuru, H. Qu, Z. Yu, and H. Mo. 2013. β-Ionone induces cell cycle arrest and apoptosis in human prostate tumor cells. Nutrition and Cancer 65 (4):600–610. doi: 10.1080/01635581.2013.776091.
   PubMed Web of Science ®Google Scholar
• Kam, S. C., J. M. Do, J. H. Choi, B. T. Jeon, G. S. Roh, and J. S. Hyun. 2012. In vivo and in vitro animal investigation of the effect of a mixture of herbal extracts from Tribulus terrestris and Cornus officinalis on penile erection. The Journal of Sexual Medicine 9 (10):2544–2551. doi: 10.1111/j.1743-6109.2012.02889.x.
   PubMed Web of Science ®Google Scholar
• Key, T. J., P. N. Appleby, R. C. Travis, D. Albanes, A. J. Alberg, A. Barricarte, A. Black, H. Boeing, H. B. Bueno-de-Mesquita, J. M. Chan, Endogenous Hormones Nutritional Biomarkers, et al. 2015. Carotenoids, retinol, tocopherols, and prostate cancer risk: Pooled analysis of 15 studies. The American Journal of Clinical Nutrition 102 (5):1142–1157. doi: 10.3945/ajcn.115.114306.
   PubMed Web of Science ®Google Scholar
• Khorsan, R., I. D. Coulter, C. Crawford, and A.-F. Hsiao. 2011. Systematic review of integrative health care research: Randomized control trials, clinical controlled trials, and meta-analysis. Evidence-Based Complementary and Alternative Medicine 2011:1–10. doi: 10.1155/2011/636134.
   Web of Science ®Google Scholar
• Kim, J. H., Y. Kinugasa, S. E. Hwang, G. Murakami, J. F. Rodríguez-Vázquez, and B. H. Cho. 2015. Denonvilliers’ fascia revisited. Surgical and Radiologic Anatomy: SRA 37 (2):187–97. doi: 10.1007/s00276-014-1336-0.
   PubMed Web of Science ®Google Scholar
• Klempner, S. J., and G. Bubley. 2012. Complementary and alternative medicines in prostate cancer: From bench to bedside? The Oncologist 17 (6):830–837. doi: 10.1634/theoncologist.2012-0094.
   PubMed Web of Science ®Google Scholar
• Klotz, L. 2013. Active surveillance for prostate cancer: Overview and update. Current Treatment Options in Oncology 14 (1):97–108. doi: 10.1007/s11864-012-0221-5.
   PubMed Web of Science ®Google Scholar
• Koca, H. B., T. Köken, M. Özkurt, K. Gökhan, S. Kabadere, N. Erkasap, K. Oğuzhan, and Ö. Çolak. 2018. Effects of Acorus calamus plant extract on prostate cancer cell culture. Anatolian Journal of Botany 2 (1):46–51. doi: 10.30616/ajb.391985.
   Google Scholar
• Kopp, W. 2018. Diet-induced hyperinsulinemia as a key factor in the etiology of both benign prostatic hyperplasia and essential hypertension? Nutrition and Metabolic Insights 11:1178638818773072. doi: 10.1177/1178638818773072.
   Web of Science ®Google Scholar
• Kumar, N., W. Rungseevijitprapa, N.-A. Narkkhong, M. Suttajit, and C. Chaiyasut. 2012. 5α-reductase inhibition and hair growth promotion of some Thai plants traditionally used for hair treatment. Journal of Ethnopharmacology 139 (3):765–771. doi: 10.1016/j.jep.2011.12.010.
   PubMed Web of Science ®Google Scholar
• Kumar, V., M. R. Kural, B. Pereira, and P. Roy. 2008. Spearmint induced hypothalamic oxidative stress and testicular anti-androgenicity in male rats - altered levels of gene expression, enzymes and hormones. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 46 (12):3563–3570. doi: 10.1016/j.fct.2008.08.027.
   PubMed Web of Science ®Google Scholar
• Kwon, O.-J., B. Zhang, L. Zhang, and L. Xin. 2016. High fat diet promotes prostatic basal-to-luminal differentiation and accelerates initiation of prostate epithelial hyperplasia originated from basal cells. Stem Cell Research 16 (3):682–91. doi: 10.1016/j.scr.2016.04.009.
   PubMed Web of Science ®Google Scholar
• Langan, R. C. 2019. Benign prostatic hyperplasia. Primary Care 46 (2):223–32. doi: 10.1016/j.pop.2019.02.003.
   PubMed Web of Science ®Google Scholar
• Lawson, K. A., M. E. Wright, A. Subar, T. Mouw, A. Hollenbeck, A. Schatzkin, and M. F. Leitzmann. 2007. Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study. Journal of the National Cancer Institute 99 (10):754–764. doi: 10.1093/jnci/djk177.
   PubMedGoogle Scholar
• Lazarevic, B., C. Hammarström, J. Yang, H. Ramberg, L. M. Diep, S. J. Karlsen, O. Kucuk, F. Saatcioglu, K. A. Taskèn, and A. Svindland. 2012. The effects of short-term genistein intervention on prostate biomarker expression in patients with localised prostate cancer before radical prostatectomy. The British Journal of Nutrition 108 (12):2138–47. doi: 10.1017/S0007114512000384.
   PubMed Web of Science ®Google Scholar
• Lee, D. S., H.-S. Choe, H. Y. Kim, S. W. Kim, S. R. Bae, B. I. Yoon, and S.-J. Lee. 2016. Acute bacterial prostatitis and abscess formation. BMC Urology 16 (1):38. doi: 10.1186/s12894-016-0153-7.
   PubMedGoogle Scholar
• Lee, J., S. Lee, S.-L. Kim, J. W. Choi, J. Y. Seo, D. J. Choi, and Y. I. Park. 2014. Corn silk maysin induces apoptotic cell death in PC-3 prostate cancer cells via mitochondria-dependent pathway. Life Sciences 119 (1-2):47–55. doi: 10.1016/j.lfs.2014.10.012.
   PubMed Web of Science ®Google Scholar
• Leitzmann, M. F., M. J. Stampfer, K. Wu, G. A. Colditz, W. C. Willett, and E. L. Giovannucci. 2003. Zinc supplement use and risk of prostate cancer. Journal of the National Cancer Institute 95 (13):1004–7. doi: 10.1093/jnci/95.13.1004.
   PubMedGoogle Scholar
• Lepor, H. 2005. Pathophysiology of benign prostatic hyperplasia in the aging male population. Reviews in Urology 7 (Suppl 4):S3.
   Google Scholar
• Lesinski, G. B., P. K. Reville, T. A. Mace, G. S. Young, J. Ahn-Jarvis, J. Thomas-Ahner, Y. Vodovotz, Z. Ameen, E. Grainger, K. Riedl, et al. 2015. Consumption of soy isoflavone enriched bread in men with prostate cancer is associated with reduced proinflammatory cytokines and immunosuppressive cells. Cancer Prevention Research (Philadelphia, PA) 8 (11):1036–44. doi: 10.1158/1940-6207.CAPR-14-0464.
   PubMed Web of Science ®Google Scholar
• Li, C., M. Imai, T. Matsuura, S. Hasegawa, M. Yamasaki, and N. Takahashi. 2016. Inhibitory effects of retinol are greater than retinoic acid on the growth and adhesion of human refractory cancer cells. Biological & Pharmaceutical Bulletin 39 (4):636–640. doi: 10.1248/bpb.b15-00794.
   PubMed Web of Science ®Google Scholar
• Li, X. M., L. Zhang, J. Li, Y. Li, H. L. Wang, G. Y. Ji, M. Kuwahara, and X. J. Zhao. 2005. Measurement of serum zinc improves prostate cancer detection efficiency in patients with PSA levels between 4 ng/mL and 10 ng/mL. Asian Journal of Andrology 7 (3):323–8. doi: 10.1111/j.1745-7262.2005.00044.x.
   PubMed Web of Science ®Google Scholar
• Liang, P., S. M. Henning, S. Schokrpur, L. Wu, N. Doan, J. Said, T. Grogan, D. Elashoff, P. Cohen, and W. J. Aronson. 2016. Effect of dietary omega-3 fatty acids on tumor-associated macrophages and prostate cancer progression. The Prostate 76 (14):1293–302. doi: 10.1002/pros.23218.
   PubMed Web of Science ®Google Scholar
• Lin, P.-H., W. Aronson, and S. J. Freedland. 2015. Nutrition, dietary interventions and prostate cancer: The latest evidence. BMC Medicine 13 (1):3. doi: 10.1186/s12916-014-0234-y.
   PubMedGoogle Scholar
• Link, C. L., S. J. Pulliam, P. M. Hanno, S. A. Hall, P. W. Eggers, J. W. Kusek, and J. B. McKinlay. 2008. Prevalence and psychosocial correlates of symptoms suggestive of painful bladder syndrome: Results from the Boston area community health survey. The Journal of Urology 180 (2):599–606. doi: 10.1016/j.juro.2008.04.009.
   PubMed Web of Science ®Google Scholar
• Liverman, C. T., and D. G. Blazer. 2004. Testosterone and aging: clinical research directions. Washington, DC: National Academies Press.
   Google Scholar
• Login, I. S., M. O. Thorner, and R. M. MacLeod. 1983. Zinc may have a physiological role in regulating pituitary prolactin secretion. Neuroendocrinology 37 (5):317–20. doi: 10.1159/000123568.
   PubMed Web of Science ®Google Scholar
• Long, N., S. Suzuki, S. Sato, A. Naiki‐Ito, K. Sakatani, T. Shirai, and S. Takahashi. 2013. Purple corn color inhibition of prostate carcinogenesis by targeting cell growth pathways. Cancer Science 104 (3):298–303. doi: 10.1111/cas.12078.
   PubMed Web of Science ®Google Scholar
• Longcope, C., H. A. Feldman, J. B. McKinlay, and A. B. Araujo. 2000. Diet and sex hormone-binding globulin. The Journal of Clinical Endocrinology & Metabolism 85 (1):293–6. doi: 10.1210/jcem.85.1.6291.
   PubMed Web of Science ®Google Scholar
• Lotan, Y., X. C. Xu, M. Shalev, R. Lotan, R. Williams, T. M. Wheeler, T. C. Thompson, and D. Kadmon. 2000. Differential expression of nuclear retinoid receptors in normal and malignant prostates. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 18 (1):116. doi: 10.1200/JCO.2000.18.1.116.
   PubMed Web of Science ®Google Scholar
• Lu, X.-P., S. San, Z. Li, Y. Luo, C. Liao, and Z. Ning. 2006. Compositions of flavones and long chain fatty acid derivatives isolated from plants and methods related thereto for the control of prostate disorders. U.S. Patent Application No. 20060252708(A1). Washington, DC: U.S. Patent and Trademark Office.
   Google Scholar
• Ma, R. L., and K. Chapman. 2009. A systematic review of the effect of diet in prostate cancer prevention and treatment. Journal of Human Nutrition and Dietetics: The Official Journal of the British Dietetic Association 22 (3):187–199. doi: 10.1111/j.1365-277X.2009.00946.x.
   PubMed Web of Science ®Google Scholar
• Madersbacher, S., C. G. Roehrborn, and M. Oelke. 2020. The role of novel minimally invasive treatments for lower urinary tract symptoms associated with benign prostatic hyperplasia. BJU International 126 (3):317–26. doi: 10.1111/bju.15154.
   PubMed Web of Science ®Google Scholar
• Major, J. M., K. Yu, S. J. Weinstein, S. I. Berndt, P. L. Hyland, M. Yeager, S. Chanock, and D. Albanes. 2014. Genetic variants reflecting higher vitamin e status in men are associated with reduced risk of prostate cancer. The Journal of Nutrition 144 (5):729–733. doi: 10.3945/jn.113.189928.
   PubMed Web of Science ®Google Scholar
• Masko, E. M., J. A. Thomas, J. A. Antonelli, J. C. Lloyd, T. E. Phillips, S. H. Poulton, M. W. Dewhirst, S. V. Pizzo, and S. J. Freedland. 2010. Low-carbohydrate diets and prostate cancer: How low is “low enough”? Cancer Prevention Research 3 (9):1124–31. doi: 10.1158/1940-6207.CAPR-10-0071.
   PubMed Web of Science ®Google Scholar
• Mavropoulos, J. C., W. B. Isaacs, S. V. Pizzo, and S. J. Freedland. 2006. Is there a role for a low-carbohydrate ketogenic diet in the management of prostate cancer? Urology 68 (1):15–8. doi: 10.1016/j.urology.2006.03.073.
   PubMed Web of Science ®Google Scholar
• McCullough, A. R. 2005. Sexual dysfunction after radical prostatectomy. Reviews in Urology 7 (Suppl 2):S3.
   PubMedGoogle Scholar
• Muscaritoli, M., J. Arends, P. Bachmann, V. Baracos, N. Barthelemy, H. Bertz, F. Bozzetti, E. Hütterer, E. Isenring, S. Kaasa, et al. 2021. ESPEN practical guideline: Clinical Nutrition in cancer. Clinical Nutrition (Edinburgh, Scotland) 40 (5):2898–2913. doi: 10.1016/j.clnu.2021.02.005.
   PubMed Web of Science ®Google Scholar
• Nakić, S. N., D. Rade, D. Škevin, D. Štrucelj, Ž. Mokrovčak, and M. Bartolić. 2006. Chemical characteristics of oils from naked and husk seeds of Cucurbita pepo L. European Journal of Lipid Science and Technology 108 (11):936–943. doi: 10.1002/ejlt.200600161.
   Web of Science ®Google Scholar
• Nash, S. H., C. Till, X. Song, M. S. Lucia, H. L. Parnes, I. M. Thompson, S. M. Lippman, E. A. Platz, and J. Schenk. 2015. Serum retinol and carotenoid concentrations and prostate cancer risk: Results from the Prostate Cancer Prevention Trial. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 24 (10):1507–1515. doi: 10.1158/1055-9965.EPI-15-0394.
   PubMed Web of Science ®Google Scholar
• Nehikhare, O., V. Kasivisvanathan, H. Ellis, and B. Challacombe. 2018. Anatomy, physiology and pathology of the large prostate. In The big prostate, ed. V. Kasivisvanathan and B. Challacombe, pp. 1–10. Cham, Switzerland: Springer.
   Google Scholar
• Ngo, T. H., R. J. Barnard, P. Cohen, S. Freedland, C. Tran, F. deGregorio, Y. I. Elshimali, D. Heber, and W. J. Aronson. 2003. Effect of isocaloric low-fat diet on human LAPC-4 prostate cancer xenografts in severe combined immunodeficient mice and the insulin-like growth factor axis. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 9 (7):2734–43.
   PubMed Web of Science ®Google Scholar
• Nygren, J., J. Thacker, F. Carli, K. Fearon, S. Norderval, D. Lobo, O. Ljungqvist, M. Soop, and J. Ramirez, Enhanced Recovery After Surgery Society. 2012. Guidelines for perioperative care in elective rectal/pelvic surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations. Clinical Nutrition (Edinburgh, Scotland) 31 (6):801–816. doi: 10.1016/j.clnu.2012.08.012.
   PubMed Web of Science ®Google Scholar
• Oh, W. K., P. W. Kantoff, V. Weinberg, G. Jones, B. I. Rini, M. K. Derynck, R. Bok, M. R. Smith, G. J. Bubley, R. T. Rosen, et al. 2004. Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 22 (18):3705–3712. doi: 10.1200/JCO.2004.10.195.
   PubMed Web of Science ®Google Scholar
• Om, A.-S., and K.-W. Chung. 1996. Dietary zinc deficiency alters 5 alpha-reduction and aromatization of testosterone and androgen and estrogen receptors in rat liver. The Journal of Nutrition 126 (4):842–8. doi: 10.1093/jn/126.4.842.
   PubMed Web of Science ®Google Scholar
• Ornish, D., M. J. M. Magbanua, G. Weidner, V. Weinberg, C. Kemp, C. Green, M. D. Mattie, R. Marlin, J. Simko, K. Shinohara, et al. 2008. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proceedings of the National Academy of Sciences 105 (24):8369–8374. doi: 10.1073/pnas.0803080105.
   PubMed Web of Science ®Google Scholar
• Parker, C., E. Castro, K. Fizazi, A. Heidenreich, P. Ost, G. Procopio, B. Tombal, and S. Gillessen, ESMO Guidelines Committee. 2020. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology: Official Journal of the European Society for Medical Oncology 31 (9):1119–1134. doi: 10.1016/j.annonc.2020.06.011.
   PubMed Web of Science ®Google Scholar
• Pusateri, D. J., W. T. Roth, J. K. Ross, and T. D. Shultz. 1990. Dietary and hormonal evaluation of men at different risks for prostate cancer: Plasma and fecal hormone-nutrient interrelationships. The American Journal of Clinical Nutrition 51 (3):371–7. doi: 10.1093/ajcn/51.3.371.
   PubMed Web of Science ®Google Scholar
• Rao, G. H. 2015. Integrative approach to health: Challenges and opportunities. Journal of Ayurveda and Integrative Medicine 6 (3):215–219.
   PubMedGoogle Scholar
• Rohrmann, S., E. Giovannucci, W. C. Willett, and E. A. Platz. 2007. Fruit and vegetable consumption, intake of micronutrients, and benign prostatic hyperplasia in US men. The American Journal of Clinical Nutrition 85 (2):523–529. doi: 10.1093/ajcn/85.2.523.
   PubMed Web of Science ®Google Scholar
• Roswall, N., S. B. Larsen, S. Friis, M. Outzen, A. Olsen, J. Christensen, L. O. Dragsted, and A. Tjønneland. 2013. Micronutrient intake and risk of prostate cancer in a cohort of middle-aged, Danish men. Cancer Causes & Control: CCC 24 (6):1129–1135. doi: 10.1007/s10552-013-0190-4.
   PubMed Web of Science ®Google Scholar
• Rycyna, K. J., D. J. Bacich, and D. S. O’Keefe. 2013. Opposing roles of folate in prostate cancer. Urology 82 (6):1197–1203. doi: 10.1016/j.urology.2013.07.012.
   PubMed Web of Science ®Google Scholar
• Sandhu, G. S., and G. L. Andriole. 2012. Overdiagnosis of prostate cancer. Journal of the National Cancer Institute. Monographs 2012 (45):146–51. doi: 10.1093/jncimonographs/lgs031.
   PubMedGoogle Scholar
• Sandhu, G. S., K. G. Nepple, Y. S. Tanagho, and G. L. Andriole. 2013. Prostate cancer chemoprevention. Seminars in Oncology 40 (3):276–85. doi: 10.1053/j.seminoncol.2013.04.003.
   PubMed Web of Science ®Google Scholar
• Schoeb, D. S., D. Schlager, M. Boeker, U. Wetterauer, M. Schoenthaler, T. R. W. Herrmann, and A. Miernik. 2017. Surgical therapy of prostatitis: A systematic review. World Journal of Urology 35 (11):1659–68. doi: 10.1007/s00345-017-2054-0.
   PubMed Web of Science ®Google Scholar
• Silva, J., C. M. Silva, and F. Cruz. 2014. Current medical treatment of lower urinary tract symptoms/BPH: Do we have a standard? Current Opinion in Urology 24 (1):21–8. doi: 10.1097/MOU.0000000000000007.
   PubMed Web of Science ®Google Scholar
• Slawin, K., D. Kadmon, S. Park, P. Scardino, M. Anzano, M. Sporn, and T. Thompson. 1993. Dietary fenretinide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras + myc-induced carcinomas in the mouse prostate reconstitution model system. Cancer Research 53 (19):4461–5.
   PubMed Web of Science ®Google Scholar
• Smailova, D. S., E. Fabbro, S. E. Ibrayev, L. Brusati, Y. M. Semenova, U. S. Samarova, F. S. Rakhimzhanova, S. M. Zhussupov, Z. A. Khismetova, and H. Hosseini. 2020. Epidemiological and economic evaluation of a pilot prostate cancer screening program. Prostate Cancer 2020:6140623. doi: 10.1155/2020/6140623.
   PubMed Web of Science ®Google Scholar
• Smailova, D., E. Ospanov, M. Gazaliyeva, D. Kaidarova, O. Shatkovskaya, Z. Zamanbekova, K. Amrenova, T. Belikhina, T. Adylkhanov, A. Omarbekov, et al. 2019. Epidemiology of prostate cancer in the Republic of Kazakhstan. Iranian Journal of Public Health 48 (12):2216–23. doi: 10.18502/ijph.v48i12.3554.
   PubMed Web of Science ®Google Scholar
• Steenkamp, V. 2003. Phytomedicines for the prostate. Fitoterapia 74 (6):545–52. doi: 10.1016/S0367-326X(03)00155-2.
   PubMed Web of Science ®Google Scholar
• Suzuki, S., E. A. Platz, I. Kawachi, W. C. Willett, and E. Giovannucci. 2002. Intakes of energy and macronutrients and the risk of benign prostatic hyperplasia. The American Journal of Clinical Nutrition 75 (4):689–97. doi: 10.1093/ajcn/75.4.689.
   PubMed Web of Science ®Google Scholar
• Teo, M. Y., D. E. Rathkopf, and P. Kantoff. 2019. Treatment of advanced prostate cancer. Annual Review of Medicine 70:479–99. doi: 10.1146/annurev-med-051517-011947.
   PubMed Web of Science ®Google Scholar
• Tewari, A. K., R. D. Pollak, M. Zhao, Y. Febbo, P. G. Cohen, P. Hwang, D. Devi, G. Demark-Wahnefried, W. Westman, E. C. Peterson, et al. 2009. The effects of varying dietary carbohydrate and fat content on survival in a murine LNCaP prostate cancer xenograft model. Cancer Prevention Research 2 (6):557–65. doi: 10.1158/1940-6207.CAPR-08-0188.
   PubMed Web of Science ®Google Scholar
• Thaller, C., M. Shalev, A. Frolov, G. Eichele, T. C. Thompson, R. H. Williams, O. Dillioglugil, and D. Kadmon. 2000. Fenretinide therapy in prostate cancer: Effects on tissue and serum retinoid concentration. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 18 (22):3804–3808. doi: 10.1200/JCO.2000.18.22.3804.
   PubMed Web of Science ®Google Scholar
• Thorpe, A., and D. Neal. 2003. Benign prostatic hyperplasia. The Lancet 361 (9366):1359–67. doi: 10.1016/S0140-6736(03)13073-5.
   PubMed Web of Science ®Google Scholar
• Tomaszewski, J. J., E. L. Richman, N. Sadetsky, D. S. O’Keefe, P. R. Carroll, B. J. Davies, and J. M. Chan. 2014. Impact of folate intake on prostate cancer recurrence following definitive therapy: Data from CaPSURE™. The Journal of Urology 191 (4):971–976. doi: 10.1016/j.juro.2013.09.065.
   PubMed Web of Science ®Google Scholar
• Travis, R. C., N. E. Allen, P. N. Appleby, A. Price, R. Kaaks, J. Chang-Claude, H. Boeing, K. Aleksandrova, A. Tjønneland, N. F. Johnsen, et al. 2012. Prediagnostic concentrations of plasma genistein and prostate cancer risk in 1,605 men with prostate cancer and 1,697 matched control participants in EPIC. Cancer Causes & Control: CCC 23 (7):1163–71. doi: 10.1007/s10552-012-9985-y.
   PubMed Web of Science ®Google Scholar
• Van Die, M. D., K. M. Bone, J. Emery, S. G. Williams, M. V. Pirotta, and C. J. Paller. 2016. Phytotherapeutic interventions in the management of biochemically recurrent prostate cancer: A systematic review of randomised trials. BJU International 117:17–34. doi: 10.1111/bju.13361.
   PubMed Web of Science ®Google Scholar
• van Die, M. D., K. M. Bone, S. G. Williams, and M. V. Pirotta. 2014. Soy and soy isoflavones in prostate cancer: A systematic review and meta-analysis of randomized controlled trials. BJU International 113 (5b):E119–E130. doi: 10.1111/bju.12435.
   PubMed Web of Science ®Google Scholar
• Virtamo, J., P. R. Taylor, J. Kontto, S. Männistö, M. Utriainen, S. J. Weinstein, J. Huttunen, and D. Albanes. 2014. Effects of α-tocopherol and β-carotene supplementation on cancer incidence and mortality: 18-year postintervention follow-up of the Alpha-tocopherol, Beta-carotene Cancer Prevention Study. International Journal of Cancer 135 (1):178–185. doi: 10.1002/ijc.28641.
   PubMed Web of Science ®Google Scholar
• Volkert, D., A. M. Beck, T. Cederholm, A. Cruz-Jentoft, S. Goisser, L. Hooper, E. Kiesswetter, M. Maggio, A. Raynaud-Simon, C. C. Sieber, et al. 2019. ESPEN guideline on clinical nutrition and hydration in geriatrics. Clinical Nutrition (Edinburgh, Scotland) 38 (1):10–47. doi: 10.1016/j.clnu.2018.05.024.
   PubMed Web of Science ®Google Scholar
• Wada, N., D. Kikuchi, J. Tateoka, N. Abe, H. Banjo, M. Tsuchida, J. Hori, G. Tamaki, M. Kita, and H. Kakizaki. 2019. Long-term symptomatic outcome after transurethral resection of the prostate: A urodynamics-based assessment. International Journal of Urology: Official Journal of the Japanese Urological Association 26 (11):1071–5. doi: 10.1111/iju.14104.
   PubMed Web of Science ®Google Scholar
• Wallner, L. P., J. Q. Clemens, and A. V. Sarma. 2009. Prevalence of and risk factors for prostatitis in African American men: The Flint Men’s Health Study. The Prostate 69 (1):24–32. doi: 10.1002/pros.20846.
   PubMed Web of Science ®Google Scholar
• Wang, L., H. D. Sesso, R. J. Glynn, W. G. Christen, V. Bubes, J. E. Manson, J. E. Buring, and J. M. Gaziano. 2014. Vitamin E and C supplementation and risk of cancer in men: Posttrial follow-up in the Physicians’ Health Study II randomized trial. The American Journal of Clinical Nutrition 100 (3):915–923. doi: 10.3945/ajcn.114.085480.
   PubMed Web of Science ®Google Scholar
• Wang, R., Y. Zheng, J.-Y. Huang, A.-Q. Zhang, Y.-H. Zhou, and J.-N. Wang. 2014. Folate intake, serum folate levels, and prostate cancer risk: A meta-analysis of prospective studies. BMC Public Health 14:1326. doi: 10.1186/1471-2458-14-1326.
   PubMed Web of Science ®Google Scholar
• Weimann, A., M. Braga, F. Carli, T. Higashiguchi, M. Hübner, S. Klek, A. Laviano, O. Ljungqvist, D. N. Lobo, R. Martindale, et al. 2017. ESPEN guideline: Clinical nutrition in surgery. Clinical Nutrition (Edinburgh, Scotland) 36 (3):623–650. doi: 10.1016/j.clnu.2017.02.013.
   PubMed Web of Science ®Google Scholar
• Weinstein, S. J., U. Peters, J. Ahn, M. D. Friesen, E. Riboli, R. B. Hayes, and D. Albanes. 2012. Serum α-tocopherol and γ-tocopherol concentrations and prostate cancer risk in the PLCO Screening Trial: A nested case-control study. PloS One 7 (7):e40204. doi: 10.1371/journal.pone.0040204.
   PubMed Web of Science ®Google Scholar
• Weisser, H., and M. Krieg. 1998. Fatty acid composition of phospholipids in epithelium and stroma of human benign prostatic hyperplasia. The Prostate 36 (4):235–43. doi: 10.1002/(SICI)1097-0045(19980901)36:4<235::AID-PROS4>3.0.CO;2-E.
   PubMed Web of Science ®Google Scholar
• Wild, C., E. Weiderpass, and B. Stewart. 2020. World Cancer Report: Cancer Research for cancer prevention. Lyon, France: International Agency for Research on Cancer. Licence: CC BY-NC-ND 3.0 IGO.
   Google Scholar
• Williams, C. D., B. M. Whitley, C. Hoyo, D. J. Grant, G. G. Schwartz, J. C. Presti, Jr, J. D. Iraggi, K. A. Newman, L. Gerber, and L. A. Taylor. 2011. Dietary calcium and risk for prostate cancer: A case-control study among US veterans. Preventing Chronic Disease 9:E39. doi: 10.5888/pcd9.110125.
   Web of Science ®Google Scholar
• Wilson, K. M., I. M. Shui, L. A. Mucci, and E. Giovannucci. 2015. Calcium and phosphorus intake and prostate cancer risk: A 24-y follow-up study. The American Journal of Clinical Nutrition 101 (1):173–183. doi: 10.3945/ajcn.114.088716.
   PubMed Web of Science ®Google Scholar
• Wu, C., and F. Gu. 1991. The prostate in eunuchs. Progress in Clinical and Biological Research 370:249–55.
   PubMedGoogle Scholar
• Xu, H., H. Jiang, and Q. Ding. 2015. Insulin-Like growth factor 1 related pathways and high-fat diet promotion of transgenic adenocarcinoma mouse prostate (TRAMP) cancer progression. Actas Urológicas Españolas (English Edition) 39 (3):161–8. doi: 10.1016/j.acuroe.2015.02.005.
   Google Scholar
• Yang, M., S. A. Kenfield, E. L. Van Blarigan, K. M. Wilson, J. L. Batista, H. D. Sesso, J. Ma, M. J. Stampfer, and J. E. Chavarro. 2015. Dairy intake after prostate cancer diagnosis in relation to disease-specific and total mortality. International Journal of Cancer 137 (10):2462–9. doi: 10.1002/ijc.29608.
   PubMed Web of Science ®Google Scholar
• Young, N. J., C. Metcalfe, D. Gunnell, M.-A. Rowlands, J. A. Lane, R. Gilbert, K. N. L. Avery, M. Davis, D. E. Neal, F. C. Hamdy, et al. 2012. A cross-sectional analysis of the association between diet and insulin-like growth factor (IGF)-I, IGF-II, IGF-binding protein (IGFBP)-2, and IGFBP-3 in men in the United Kingdom. Cancer Causes & Control: CCC 23 (6):907–17. doi: 10.1007/s10552-012-9961-6.
   PubMed Web of Science ®Google Scholar
• Younis, Y., S. Ghirmay, and S. Al-Shihry. 2000. African Cucurbita pepo L.: Properties of seed and variability in fatty acid composition of seed oil. Phytochemistry 54 (1):71–75. doi: 10.1016/S0031-9422(99)00610-X.
   PubMed Web of Science ®Google Scholar
• Zaidi, N., D. Thomas, and B. Chughtai. 2018. Management of chronic prostatitis (CP). Current Urology Reports 19 (11):88. doi: 10.1007/s11934-018-0841-9.
   PubMed Web of Science ®Google Scholar
• Zhang, S. X., B. Yu, S. Guo, Y. Wang, and C. K. Yin. 2003. Comparison of incidence of BPH and related factors between urban and rural inhabitants in district of Wannan. Zhonghua Nan ke Xue = National Journal of Andrology 9 (1):45–7.
   PubMedGoogle Scholar
• Zuniga, K. B., J. M. Chan, C. J. Ryan, and S. A. Kenfield. 2020. Diet and lifestyle considerations for patients with prostate cancer. Urologic Oncology 38 (3):105–17. doi: 10.1016/j.urolonc.2019.06.018.
   Google Scholar